Antiplatelet drugs in femoropopliteal vein bypasses: a multicenter trial.

[1]  C. McCollum,et al.  Influence of smoking and plasma factors on patency of femoropopliteal vein grafts. , 1989, BMJ.

[2]  A. Nicolaides,et al.  Femorodistal vein bypass graft stenoses , 1988, The British journal of surgery.

[3]  Thomas E. Moritz,et al.  Improvement in early saphenous vein graft patency after coronary artery bypass surgery with antiplatelet therapy: results of a Veterans Administration Cooperative Study. , 1988, Circulation.

[4]  P. Clifford,et al.  Inflow site: Its effect on femoropopliteal and distal graft patency , 1988, The British journal of surgery.

[5]  M. Schemper,et al.  The influence of anticoagulant treatment on the probability of function in femoropopliteal vein bypass surgery: analysis of a clinical series (1970 to 1985) and interim evaluation of a controlled clinical trial. , 1987, Surgery.

[6]  J. Webster,et al.  Random control trial of a short course of aspirin and dipyridamole (Persantin) for femorodistal grafts , 1987, The British journal of surgery.

[7]  P. Harris,et al.  Prospectively randomized clinical trial to compare in situ and reversed saphenous vein grafts for femoropopliteal bypass , 1987, The British journal of surgery.

[8]  M. Schemper,et al.  Influence of anticoagulant treatment in preventing graft occlusion following saphenous vein bypass for femoropopliteal occlusive disease , 1986, The British journal of surgery.

[9]  V. Fuster,et al.  Role of platelets and platelet inhibitors in aortocoronary artery vein-graft disease. , 1986, Circulation.

[10]  R. Kester,et al.  The Influence of Platelet Inhibition on the Patency of Femoro-Popliteal Dacron Bypass Grafts , 1985 .

[11]  J. Pepper,et al.  Randomised placebo controlled trial of aspirin and dipyridamole in the prevention of coronary vein graft occlusion. , 1985, British heart journal.

[12]  M. Donaldson,et al.  Effect of aspirin and dipyridamole on the patency of lower extremity bypass grafts. , 1984, Surgery.

[13]  V. Fuster,et al.  Effect of dipyridamole and aspirin on late vein-graft patency after coronary bypass operations. , 1984, The New England journal of medicine.

[14]  C. Mccollum,et al.  Does 111indium‐platelet deposition predict patency in prosthetic arterial grafts? , 1983, The British journal of surgery.

[15]  D. Brewster,et al.  Femoropopliteal graft failures. Clinical consequences and success of secondary reconstructions. , 1983, Archives of surgery.

[16]  J. S. Yao,et al.  Randomization of autogenous vein and polytetrafluorethylene grafts in femoral-distal reconstruction. , 1982, Surgery.

[17]  R. Green,et al.  Effects of aspirin and dipyridamole on expanded polytetrafluoroethylene graft patency. , 1982, Surgery.

[18]  V. Fuster,et al.  A platelet-inhibitor-drug trial in coronary-artery bypass operations: benefit of perioperative dipyridamole and aspirin therapy on early postoperative vein-graft patency. , 1982, The New England journal of medicine.

[19]  B. Buxton,et al.  The significance of vein wall thickness and diameter in relation to the patency of femoropopliteal saphenous vein bypass grafts. , 1980, Surgery.

[20]  J. P. Elliott,et al.  Autogenous vein grafting in femoropopliteal atherosclerosis: the limits of its effectiveness. , 1979, Surgery.